Literature DB >> 1663696

Cognitive impairment among alcoholics: impact on drink refusal skill acquisition and treatment outcome.

D E Smith1, B S McCrady.   

Abstract

The impact of neuropsychological impairment on drink refusal skill acquisition and treatment outcome was examined in 33 male alcoholic inpatients. Subjects stratified by Abstraction scores on the Shipley Institute of Living Scale (SILS) performed differentially on drink refusal components of the Situational Competency Test (SCT) following a skills-based drink refusal intervention. Higher abstraction subjects tended to respond more rapidly on the SCT at post-training, had significantly higher scores on a quiz about effective drink refusal at baseline, and tended to improve more on the quiz following training than subjects with lower conceptual functioning. Aftercare attendance was significantly greater among the higher neuropsychological functioning group. When subjects were categorized by Brain Age Quotient no differences were found in skill acquisition nor in aftercare attendance. Subjects who showed the most learning on the California Verbal Learning Test demonstrated significantly better performance on the drink refusal quiz at post-training. Implications for alcoholism treatment are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1663696     DOI: 10.1016/0306-4603(91)90019-e

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  12 in total

1.  Drink refusal training as part of a combined behavioral intervention: effectiveness and mechanisms of change.

Authors:  Katie Witkiewitz; Dennis M Donovan; Bryan Hartzler
Journal:  J Consult Clin Psychol       Date:  2012-01-30

2.  Self-efficacy for cocaine abstinence: pretreatment correlates and relationship to outcomes.

Authors:  Sara L Dolan; Rosemarie A Martin; Damaris J Rohsenow
Journal:  Addict Behav       Date:  2007-12-07       Impact factor: 3.913

3.  Alcohol use biomarkers predicting cognitive performance: a secondary analysis in veterans with alcohol dependence and posttraumatic stress disorder.

Authors:  Raj K Kalapatapu; Kevin L Delucchi; Brooke A Lasher; Sophia Vinogradov; Steven L Batki
Journal:  Mil Med       Date:  2013-09       Impact factor: 1.437

4.  Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure.

Authors:  Marc L Copersino; David J Schretlen; Garrett M Fitzmaurice; Scott E Lukas; Judith Faberman; Jody Sokoloff; Roger D Weiss
Journal:  Am J Drug Alcohol Abuse       Date:  2012-03-26       Impact factor: 3.829

5.  Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change.

Authors:  Marsha E Bates; Anthony P Pawlak; J Scott Tonigan; Jennifer F Buckman
Journal:  Psychol Addict Behav       Date:  2006-09

6.  Association of alcohol use biomarkers and cognitive performance in veterans with problematic alcohol use and posttraumatic stress disorder: data from the mind your heart study.

Authors:  Raj K Kalapatapu; Thomas C Neylan; Mathilda C Regan; Beth E Cohen
Journal:  J Addict Dis       Date:  2014

Review 7.  Cognitive functioning in bipolar and co-occurring substance use disorders: a missing piece of the puzzle.

Authors:  Boaz Levy; Roger D Weiss
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

8.  A Web-Based Behavior Therapy Program Influences the Association Between Cognitive Functioning and Retention and Abstinence in Clients Receiving Methadone Maintenance Treatment.

Authors:  Michelle C Acosta; Lisa A Marsch; Haiyi Xie; Honoria Guarino; Yesenia Aponte-Melendez
Journal:  J Dual Diagn       Date:  2012-10

Review 9.  Cognitive rehabilitation of chronic alcohol abusers.

Authors:  D N Allen; G Goldstein; B E Seaton
Journal:  Neuropsychol Rev       Date:  1997-03       Impact factor: 7.444

10.  Rapid cognitive screening of patients with substance use disorders.

Authors:  Marc L Copersino; William Fals-Stewart; Garrett Fitzmaurice; David J Schretlen; Jody Sokoloff; Roger D Weiss
Journal:  Exp Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.